[Epidermolysis bullosa and pemphigus].
Imamura
S
S
Department of Dermatology, Faculty of Medicine, Kyoto University.
Sasai
Y
Y
Hashimoto
I
I
Ogawa
H
H
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D004820:Epidermolysis Bullosa / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007564:Japan / Q000453:epidemiology; D008875:Middle Aged; D010392:Pemphigus / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D012015:Reference Standards; D012737:Sex Factors; D014810:Vitamin E / Q000008:administration & dosage
D007166:Immunosuppressive Agents; D014810:Vitamin E; D011239:Prednisolone